AVIRAGEN THERAPEUTICS INC
Q2 2017 13F Holders
CUSIP
053761102
Type
Equity
Class
COM
Num filings
32
Total reported value, excl. options
$6.17 M
Compare 2017 Q2 to
2018 Q1
2017 Q4
2017 Q3
2017 Q1
2016 Q4
2016 Q3
2016 Q2
2016 Q1
Manager
Report Date
Value ($000)
Shares
Option Type